Next Article in Journal
Impact of Soluble HLA-G Levels and Endometrial NK Cells in Uterine Flushing Samples from Primary and Secondary Unexplained Infertile Women
Next Article in Special Issue
Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma
Previous Article in Journal
Exploring the Secrets of Long Noncoding RNAs
Previous Article in Special Issue
Expression of IL-8, IL-6 and IL-1β in Tears as a Main Characteristic of the Immune Response in Human Microbial Keratitis
Open AccessArticle

Helper T Lymphocyte Response in the Peripheral Blood of Patients with Intraepithelial Neoplasia Submitted to Immunotherapy with Pegylated Interferon-α

1
Oncology Research Institute (IPON), Federal University of the TriânguloMineiro (UFTM), Uberaba, Minas Gerais 38022-200, Brazil
2
Discipline of Immunology, UFTM, Uberaba, Minas Gerais 38022-200, Brazil
3
Discipline of Gynecology and Obstetrics, UFTM, Uberaba, Minas Gerais 38022-200, Brazil
*
Author to whom correspondence should be addressed.
Academic Editor: Kamal D. Moudgil
Int. J. Mol. Sci. 2015, 16(3), 5497-5509; https://doi.org/10.3390/ijms16035497
Received: 16 November 2014 / Revised: 19 February 2015 / Accepted: 27 February 2015 / Published: 10 March 2015
(This article belongs to the Special Issue Mechanism of Action and Applications of Cytokines in Immunotherapy)
Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is imperative. The objective of this study was to evaluate the production of cytokines in helper T (CD4+) lymphocytes during immunotherapy with pegylated IFN-α in patients with cervical intraepithelial neoplasia (CIN). We conducted a prospective study with 17 patients with CIN II-III using immunotherapy with pegylated IFN-α subcutaneouly weekly, and using flow cytometry we evaluated the peripheric CD4+ T lymphocytes. The results show that in the regression group the patients presented a significant increase in the amount of IFN-γ during the entire immunotherapy, compared with the group without a response. The amount of CD4+ T lymphocytes positive for IL-2, IL-4, IL-10 and TGF-β is significantly lower in patients with good clinical response. The results also demonstrate that patients with regression have a higher amount of intracellular TNF-α in CD4+ T lymphocytes before the start of treatment. Analyzing these data sets, it can be concluded that immunotherapy is a viable clinical treatment for patients with high-grade CIN and that the regression is dependent on the change in the immune response to a Th1 pattern. View Full-Text
Keywords: immunotherapy; cervical cancer; IFN-α and T lymphocytes immunotherapy; cervical cancer; IFN-α and T lymphocytes
Show Figures

Figure 1

MDPI and ACS Style

Michelin, M.A.; Montes, L.; Nomelini, R.S.; Trovó, M.A.; Murta, E.F.C. Helper T Lymphocyte Response in the Peripheral Blood of Patients with Intraepithelial Neoplasia Submitted to Immunotherapy with Pegylated Interferon-α. Int. J. Mol. Sci. 2015, 16, 5497-5509.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop